82 related articles for article (PubMed ID: 24189499)
1. Development and characterization of sulfasalazine loaded fucosylated PPI dendrimer for the treatment of cytokine-induced liver damage.
Gupta R; Mehra NK; Jain NK
Eur J Pharm Biopharm; 2014 Apr; 86(3):449-58. PubMed ID: 24189499
[TBL] [Abstract][Full Text] [Related]
2. Fucosylated multiwalled carbon nanotubes for Kupffer cells targeting for the treatment of cytokine-induced liver damage.
Gupta R; Mehra NK; Jain NK
Pharm Res; 2014 Feb; 31(2):322-34. PubMed ID: 24043294
[TBL] [Abstract][Full Text] [Related]
3. Potential use of fucose-appended dendrimer/α-cyclodextrin conjugates as NF-κB decoy carriers for the treatment of lipopolysaccharide-induced fulminant hepatitis in mice.
Akao C; Tanaka T; Onodera R; Ohyama A; Sato N; Motoyama K; Higashi T; Arima H
J Control Release; 2014 Nov; 193():35-41. PubMed ID: 25020038
[TBL] [Abstract][Full Text] [Related]
4. The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosis.
Rodenburg RJ; Ganga A; van Lent PL; van de Putte LB; van Venrooij WJ
Arthritis Rheum; 2000 Sep; 43(9):1941-50. PubMed ID: 11014343
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrin-conjugated dendritic nanoconstructs for lung targeting of methotrexate.
Kurmi BD; Gajbhiye V; Kayat J; Jain NK
J Pharm Sci; 2011 Jun; 100(6):2311-20. PubMed ID: 21491447
[TBL] [Abstract][Full Text] [Related]
6. Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signalling, leading to control of neointimal hyperplasia.
Kim JY; Cho HJ; Sir JJ; Kim BK; Hur J; Youn SW; Yang HM; Jun SI; Park KW; Hwang SJ; Kwon YW; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
Cardiovasc Res; 2009 Jun; 82(3):550-60. PubMed ID: 19234301
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers.
Gajbhiye V; Ganesh N; Barve J; Jain NK
Eur J Pharm Sci; 2013 Mar; 48(4-5):668-79. PubMed ID: 23298577
[TBL] [Abstract][Full Text] [Related]
8. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells.
Gupta U; Dwivedi SK; Bid HK; Konwar R; Jain NK
Int J Pharm; 2010 Jun; 393(1-2):185-96. PubMed ID: 20382210
[TBL] [Abstract][Full Text] [Related]
9. Sulfasalazine Microparticles Targeting Macrophages for the Treatment of Inflammatory Diseases Affecting the Synovial Cavity.
Villa-Hermosilla MC; Fernández-Carballido A; Hurtado C; Barcia E; Montejo C; Alonso M; Negro S
Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34202859
[TBL] [Abstract][Full Text] [Related]
10. Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers.
Agashe HB; Babbar AK; Jain S; Sharma RK; Mishra AK; Asthana A; Garg M; Dutta T; Jain NK
Nanomedicine; 2007 Jun; 3(2):120-7. PubMed ID: 17572354
[TBL] [Abstract][Full Text] [Related]
11. Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits.
Mishra V; Jain NK
Int J Pharm; 2014 Jan; 461(1-2):380-90. PubMed ID: 24291772
[TBL] [Abstract][Full Text] [Related]
12. Effect of surface capping on targeting potential of folate decorated poly (propylene imine) dendrimers.
Birdhariya B; Kesharwani P; Jain NK
Drug Dev Ind Pharm; 2015; 41(8):1393-9. PubMed ID: 25163759
[TBL] [Abstract][Full Text] [Related]
13. The Dual Benefit of Sulfasalazine on Pneumocystis Pneumonia-Related Immunopathogenesis and Antifungal Host Defense Does Not Require IL-4Rα-Dependent Macrophage Polarization.
Zhang ZQ; Gigliotti F; Wright TW
Infect Immun; 2023 Apr; 91(4):e0049022. PubMed ID: 36916933
[TBL] [Abstract][Full Text] [Related]
14. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.
Volin MV; Harlow LA; Woods JM; Campbell PL; Amin MA; Tokuhira M; Koch AE
Arthritis Rheum; 1999 Sep; 42(9):1927-35. PubMed ID: 10513809
[TBL] [Abstract][Full Text] [Related]
15. Sulfasalazine alleviates neuropathic pain hypersensitivity in mice through inhibition of SGK-1 in the spinal cord.
Yasukochi S; Kusunose N; Matsunaga N; Koyanagi S; Ohdo S
Biochem Pharmacol; 2021 Mar; 185():114411. PubMed ID: 33428896
[TBL] [Abstract][Full Text] [Related]
16. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent.
Agarwal A; Gupta U; Asthana A; Jain NK
Biomaterials; 2009 Jul; 30(21):3588-96. PubMed ID: 19344947
[TBL] [Abstract][Full Text] [Related]
17. Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers.
Rust C; Bauchmuller K; Bernt C; Vennegeerts T; Fickert P; Fuchsbichler A; Beuers U
Gut; 2006 May; 55(5):719-27. PubMed ID: 16322111
[TBL] [Abstract][Full Text] [Related]
18. Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer.
Agashe HB; Dutta T; Garg M; Jain NK
J Pharm Pharmacol; 2006 Nov; 58(11):1491-8. PubMed ID: 17132212
[TBL] [Abstract][Full Text] [Related]
19. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
Jansen G; van der Heijden J; Oerlemans R; Lems WF; Ifergan I; Scheper RJ; Assaraf YG; Dijkmans BA
Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210
[TBL] [Abstract][Full Text] [Related]
20. Sulfasalazine blocks the release of proteoglycan and collagen from cytokine stimulated cartilage and down-regulates metalloproteinases.
Lakey RL; Cawston TE
Rheumatology (Oxford); 2009 Oct; 48(10):1208-12. PubMed ID: 19690126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
